Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 4,415.00
+185.00 (4.37%)
At close: Aug 20, 2026
70.46% (1Y)
| Market Cap | 230.90B +186.8% |
| Revenue (ttm) | 24.02B -19.5% |
| Net Income | -5.71B |
| EPS | -177.15 |
| Shares Out | 52.30M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 324,919 |
| Open | 4,360.00 |
| Previous Close | 4,230.00 |
| Day's Range | 4,160.00 - 4,520.00 |
| 52-Week Range | 2,440.00 - 10,180.00 |
| Beta | 0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |